1. |
马丽华, 主编. 乳腺疾病比较影像诊断学[M]. 第1版. 北京: 军事医学科学出版社; 2003.
|
2. |
刘丽军,李金发,杜冬,韩晨燕,李炎高择日电针治疗乳腺增生病的临床观察[J]中国针灸1996;16(4):7~8.
|
3. |
龚东方,杨海燕,李素荷针药结合治疗乳腺增生症的临床观察与研究[J]针刺研究,1997;22(4):271~273.
|
4. |
王玉慧,杨沈秋,马国庆内服小金丸配合针刺背俞穴治疗乳腺小叶增生病疗效观察[J].黑龙江医学,2003;27(6):441~ 442.
|
5. |
吕大鸣,贾桂芹,陈双文针刺配合中药治疗乳腺增生39例[J]中国针灸,1996;l6(6):5.
|
6. |
James P. Fibrocystic breast disease[EB/OL]. Available from: URL: http://www.umm.edu/ency/article/000912.htm.
|
7. |
NCBI. Fibrocystic Disease of Breast[EB/OL]. Available from: URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=mesh&list_uids=68005348&dopt=Full.
|
8. |
Ma LH, ed. Comparision Image Diagnostics in Breast Diseasev[M]. 1st ed. Beijing: Military Medicine Science Press; 2003.
|
9. |
Berek JS. Novak’s gynecology[M]. 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.
|
10. |
Hutter RVP. Is fibrocystic disease of the precancerous[J]? Arch Pathol Lab Med, 1986; 110(3): 171-173.
|
11. |
London SJ, Connolly JL, Schnitt SJ, Colditz. A prospective study of benigh breast disease and the risk of breast cancer[J]. JAMA, 1992; 267(7): 941-944.
|
12. |
Page DL, Dupont WD. Anatomic markers of human premalignancy and risk of breast cancer[J]. Cancer, 1990; 66(6 supplement): 1 326-1 335.
|
13. |
Page Dl. The woman at high risk for breast cancer: importance of hyperplasia[J]. Surg Clin North Am, 1996; 76(2): 223-230.
|
14. |
Simpson JF, Page Dl. Pathology of preinvasive and excellent-prognosis breast cancer[J]. Curr Opin Oncol, 1997; 9(6): 512-519.
|
15. |
Mansel RE, Harrison BJ, Melhuish J, Sheridan W, Pye JK, Pritchard G, Maddox PR, Webster DJ, Hughes LE. A randomised trial of dietary intervention with essential fatty acids in patients with categorized cysts[J]. Ann N Y Acad Sci, 1990; 586: 288-294.
|
16. |
Lv Meizhen. Clinical search of combination electro-acupuncture at Jiaji and acupuncture at Renying to treat mammary dysplasia[J]. Journal of Shandong university of TCM, 2004; 28(3): 214-216, 219.
|
17. |
Dixon JM. Cystic disease and fibroadenoma of the breast: natural history and relation to breast cancer risk[J]. Br Med Bull, 1991; 47(2): 258-271.
|
18. |
FRED. Fibrocystic Disease of Breast[EB/OL]. Available from: URL: http://fred.hmc.psu.edu/ds/retrieve/fred/meshdescriptor/D005348.
|
19. |
Maddox PR, Mansel RE. Management of breast pain and nodularit[J]. World J Surg, 1989; 13(6): 699-705.
|
20. |
Stovall, Thomas G. Clinical Manual of Gynecology[M]. 2nd ed. New York: McGraw-Hill, Inc; 1992.
|
21. |
Faiz O, Fentiman IS. Management of breast pain[J]. Int J Clin Pract, 2002; 54(4): 228-232.
|
22. |
Gateley CA, Miers M, Mansel RE, Huges LE. Drug treatments for mastalgia: 17 year experience in the Cardiff Mastalgia Clinic[J]. J R Soc Med, 1992; 85(1): 12-15.
|
23. |
Rea N, Bove F, Gentile A, Parmeggiani U. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia[J]. Gynecol Endocrinol, 1997; 88(11): 479-487.
|
24. |
Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D. Comparison of tamoxifen with danazol for treatment of cyclical mastalgia[J]. Gynecol Endocrinol, 1997; 11(6): 393-397.
|
25. |
Holland PA, Gateley CA. Drug therapy of mastalaia. What are the options[J]? Drugs, 1994; 48(5): 709-716.
|
26. |
London RS, Sundaram GS, Murphy L, Murphy L, Goldstein PJ. The effect of a-tocopherol on premenstrual symptomology a double-blind study[J]. J Am Coll Nutr, 1983; 2(2): 115-122.
|
27. |
Abraham GE, Nutritional factors in the etiology of the premenstrual tention syndromes[J]. J Reprod Med, 1983; 28(7): 446-464.
|
28. |
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials[J]. JAMA, 1995; 273(5): 408-412.
|
29. |
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary [J ] ? Control Clin Trials, 1996; 17(1): 1-12.
|
30. |
Moher D, Pham B, Jones AR, Cook DJ, Jadad A, Moher M,Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analysis[J].Lancet, 1998; 352(9128): 609-613.
|
31. |
Juni P, Altman DG, Egger M. Systematic reviews in health care:Assessing the quality of controlled clinical trials[J ]. BM J, 2001; 323(7303): 42 -46.
|
32. |
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses[J]. Ann Intern Med, 2001; 135( 11 ): 982 -989.
|
33. |
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test [ J ] v BM J, 1997; 315 (7109): 629 -634.
|
34. |
Liu LJ, LiJF, Du D, Han CY, Li YG. Clinical observation of electro-acupuncture on selective date in treating mammary dysplasia [J ].Chinese Acupuncture & Moxibustion, 1996; 16 ( 4 ): 7 - 8.
|
35. |
Gong DF, Yang HY, Li SH. Clinical observation and study: acupuncture in conjunction with medicine to treat mammary dysplasia[J]Acupuncture research, 1997; 22(4): 271 -273.
|
36. |
Wang YH, Yang SQ, Ma GQ. Curative effect observation of Xiao jinwan combined with acupuncture at Beishu in treating mammary dysplasia[J]. Hei Long Jiang Medical Journal, 2003; 27(6): 441 -442.
|
37. |
Lv DM, Jia GQ, Chen SW. Acupuncture combined with Chinese herbs to treat 39 patients with mammary dysplasia[J ]. Chinese Acupuncture & Moxibustion, 1996; 16(6): 5.
|